Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000175091 | SCV000226520 | benign | not specified | 2015-04-02 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000872950 | SCV001014854 | benign | Neuropathy, hereditary sensory and autonomic, type 2A; Pseudohypoaldosteronism type 2C | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002326954 | SCV002631219 | likely benign | Inborn genetic diseases | 2019-07-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV000872950 | SCV002804316 | likely benign | Neuropathy, hereditary sensory and autonomic, type 2A; Pseudohypoaldosteronism type 2C | 2021-07-23 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004708074 | SCV005234126 | benign | not provided | criteria provided, single submitter | not provided |